Clinical Trials
4 trialsNCT04040491 2020-05-12
PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma
Zhengzhou University
Phase 4 Unknown
NCT03631862 2018-08-15
Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
Zhengzhou University
Phase 4 Unknown
NCT03071822 2018-06-11
Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas
The University of Hong Kong
Phase 4 Unknown
NCT01664975 2016-10-05
Treatment of Peripheral T-cell Lymphoma
Zhengzhou University
Phase 4 Completed